In this TOGA Podcast, we discuss what defines operability in locally advanced stage III NSCLC. A/Professor Tim Clay, Medical Oncologist from St John of God Subiaco and Rockingham General is joined by Professor Lucy Morgan, Board Chair of the Lung Foundation of Australia and Respiratory Physician from Concord & Nepean Hospitals; A/Professor Phillip Antippa, Cardiothoracic surgeon and the Head of Thoracic Surgical Services at the Royal Melbourne Hospital and the VCCC and also Dr Qurrat van den Blink, Radiation Oncologist from GenesisCare based in Perth (Joondalup) and Albany. Support TOGA

Thank you for listening to Conversations in Lung Cancer Research. If you

enjoyed this episode, please rate and review us on Apple Podcasts or

Spotify.

---------------

Connect with TOGA

Attend an Event: https://thoraciconcology.org.au/events/

Become a Member: Join the TOGA community at

https://thoraciconcology.org.au/membership/

Donate: Support our research and treatment initiatives at

https://thoraciconcology.org.au/support-us/donate/

Follow Us

LinkedIn:

https://www.linkedin.com/company/thoracic-oncology-group-of-australasia/

X (Twitter): https://x.com/TOGAANZ

Instagram: https://www.instagram.com/togaanz/

YouTube:  https://www.youtube.com/@Thoracic_Oncology

---------------

Acknowledgement of Country

The Thoracic Oncology Group of Australasia Limited acknowledges

Traditional Owners of Country throughout Australia and recognises the

continuing connection to lands, waters and communities. We pay our

respect to Aboriginal and Torres Strait cultures; and to Elders past and

present.